¡Sorpréndeme!
Biocon Eyes First Mover Advantage With Launch Of Neulasta Biosimilar
2022-02-25
2
Dailymotion
Videos relacionados
Biocon Rallies On FDA's Letter On Mylan's Biosimilar
Biocon Outlook On The Biosimilar Sales | NDTV Profit
Biocon Says New Biosimilars To Drive Growth For Next 5 Years
Kiran Mazumdar Shaw of Biocon on biosimilar & business outlook
Biocon Jumps On FDA's Letter On Mylan's Biosimilar
Biocon Plays The Biosimilars Card
Biocon & Mylan Launch Cancer Drug In U.S.
Growth momentum to continue in Q2, H2 due to trastuzumab launch, says Biocon
Kiran Mazumdar of Biocon on launch of insulin glargine
주간아이돌 - (Weeklyidol EP.16) Kim Hyun-jung Keywords Part1
